Key Points

  • Transfusing ABO-incompatible platelets may result in worse platelet recovery and outcomes in patients with ICH.

  • ABO compatibility should be considered for platelet transfusion approaches for patients with ICH.

Abstract

Acute platelet transfusion after intracerebral hemorrhage (ICH) given in efforts to reverse antiplatelet medication effects and prevent ongoing bleeding does not appear to improve outcome and may be associated with harm. Although the underlying mechanisms are unclear, the influence of ABO-incompatible platelet transfusions on ICH outcomes has not been investigated. We hypothesized that patients with ICH who receive ABO-incompatible platelet transfusions would have worse platelet recovery (using absolute count increment [ACI]) and neurological outcomes (mortality and poor modified Rankin Scale [mRS 4-6]) than those receiving ABO-compatible transfusions. In a single-center cohort of consecutively admitted patients with ICH, we identified 125 patients receiving acute platelet transfusions, of whom 47 (38%) received an ABO-incompatible transfusion. Using quantile regression, we identified an association of ABO-incompatible platelet transfusion with lower platelet recovery (ACI, 2 × 103cells per μL vs 15 × 103cells per μL; adjusted coefficient β, −19; 95% confidence interval [CI], −35.55 to −4.44; P = .01). ABO-incompatible platelet transfusion was also associated with increased odds of mortality (adjusted odds ratio [OR], 2.59; 95% CI, 1.00-6.73; P = .05) and poor mRS (adjusted OR, 3.61; 95% CI, 0.97-13.42; P = .06); however, these estimates were imprecise. Together, these findings suggest the importance of ABO compatibility for platelet transfusions for ICH, but further investigation into the mechanism(s) underlying these observations is required.

REFERENCES

1.
Brott
T
,
Broderick
J
,
Kothari
R
, et al
.
Early hemorrhage growth in patients with intracerebral hemorrhage
.
Stroke
.
1997
;
28
(
1
):
1
-
5
.
2.
Davis
SM
,
Broderick
J
,
Hennerici
M
, et al;
Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators
.
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
.
Neurology
.
2006
;
66
(
8
):
1175
-
1181
.
3.
Brouwers
HB
,
Greenberg
SM
.
Hematoma expansion following acute intracerebral hemorrhage
.
Cerebrovasc Dis
.
2013
;
35
(
3
):
195
-
201
.
4.
Hemphill
JC
III
,
Greenberg
SM
,
Anderson
CS
, et al;
Council on Clinical Cardiology
.
Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
.
Stroke
.
2015
;
46
(
7
):
2032
-
2060
.
5.
Baharoglu
MI
,
Cordonnier
C
,
Al-Shahi Salman
R
, et al;
PATCH Investigators
.
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
.
Lancet
.
2016
;
387
(
10038
):
2605
-
2613
.
6.
Baharoglu
MI
,
Al-Shahi Salman
R
,
Cordonnier
C
, et al
.
PATCH trial: explanatory analyses
.
Blood
.
2020
;
135
(
16
):
1406
-
1409
.
7.
Lozano
M
,
Heddle
N
,
Williamson
LM
,
Wang
G
,
AuBuchon
JP
,
Dumont
LJ
;
Biomedical Excellence for Safer Transfusion Collaborative
.
Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey
.
Transfusion
.
2010
;
50
(
8
):
1743
-
1748
.
8.
Dunstan
RA
,
Simpson
MB
,
Knowles
RW
,
Rosse
WF
.
The origin of ABH antigens on human platelets
.
Blood
.
1985
;
65
(
3
):
615
-
619
.
9.
Curtis
BR
,
Edwards
JT
,
Hessner
MJ
,
Klein
JP
,
Aster
RH
.
Blood group A and B antigens are strongly expressed on platelets of some individuals
.
Blood
.
2000
;
96
(
4
):
1574
-
1581
.
10.
Heal
JM
,
Rowe
JM
,
McMican
A
,
Masel
D
,
Finke
C
,
Blumberg
N
.
The role of ABO matching in platelet transfusion
.
Eur J Haematol
.
1993
;
50
(
2
):
110
-
117
.
11.
Dunbar
NM
,
Ornstein
DL
,
Dumont
LJ
.
ABO incompatible platelets: risks versus benefit
.
Curr Opin Hematol
.
2012
;
19
(
6
):
475
-
479
.
12.
Lozano
M
,
Cid
J
.
The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility
.
Transfus Med Rev
.
2003
;
17
(
1
):
57
-
68
.
13.
Pavenski
K
,
Warkentin
TE
,
Shen
H
,
Liu
Y
,
Heddle
NM
.
Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study
.
Transfusion
.
2010
;
50
(
7
):
1552
-
1560
.
14.
Blumberg
N
,
Heal
JM
,
Hicks
GL
Jr.
,
Risher
WH
.
Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery
.
Transfusion
.
2001
;
41
(
6
):
790
-
793
.
15.
Kerkhoffs
JLH
,
Eikenboom
JCJ
,
van de Watering
LMG
,
van Wordragen-Vlaswinkel
RJ
,
Wijermans
PW
,
Brand
A
.
The clinical impact of platelet refractoriness: correlation with bleeding and survival
.
Transfusion
.
2008
;
48
(
9
):
1959
-
1965
.
16.
Triulzi
DJ
,
Assmann
SF
,
Strauss
RG
, et al
.
The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia
.
Blood
.
2012
;
119
(
23
):
5553
-
5562
.
17.
Meretoja
A
,
Strbian
D
,
Putaala
J
, et al
.
SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage
.
Stroke
.
2012
;
43
(
10
):
2592
-
2597
.
18.
Roh
DJ
,
Albers
DJ
,
Magid-Bernstein
J
, et al
.
Low hemoglobin and hematoma expansion after intracerebral hemorrhage
.
Neurology
.
2019
;
93
(
4
):
e372
-
e380
.
19.
Appelboom
G
,
Bruce
SS
,
Hickman
ZL
, et al
.
Volume-dependent effect of perihaematomal oedema on outcome for spontaneous intracerebral haemorrhages
.
J Neurol Neurosurg Psychiatry
.
2013
;
84
(
5
):
488
-
493
.
20.
Dowlatshahi
D
,
Demchuk
AM
,
Flaherty
ML
,
Ali
M
,
Lyden
PL
,
Smith
EE
;
VISTA Collaboration
.
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes
.
Neurology
.
2011
;
76
(
14
):
1238
-
1244
.
21.
Hemphill
JC
III
,
Bonovich
DC
,
Besmertis
L
,
Manley
GT
,
Johnston
SC
.
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage
.
Stroke
.
2001
;
32
(
4
):
891
-
897
.
22.
Brouwers
HB
,
Chang
Y
,
Falcone
GJ
, et al
.
Predicting hematoma expansion after primary intracerebral hemorrhage
.
JAMA Neurol
.
2014
;
71
(
2
):
158
-
164
.
23.
Lord
AS
,
Langefeld
CD
,
Sekar
P
, et al
.
Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study
.
Stroke
.
2014
;
45
(
12
):
3535
-
3542
.
24.
Goldstein
JN
,
Fazen
LE
,
Wendell
L
, et al
.
Risk of thromboembolism following acute intracerebral hemorrhage
.
Neurocrit Care
.
2009
;
10
(
1
):
28
-
34
.
25.
Zaffuto
BJ
,
Conley
GW
,
Connolly
GC
, et al
.
ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion
.
Vox Sang
.
2016
;
110
(
3
):
219
-
226
.
26.
De la Salle
BJ
,
McTaggart
PN
,
Briggs
C
, et al
.
The accuracy of platelet counting in thrombocytopenic blood samples distributed by the UK National External Quality Assessment Scheme for General Haematology
.
Am J Clin Pathol
.
2012
;
137
(
1
):
65
-
74
.
27.
Tsuda
I
,
Hino
M
,
Takubo
T
, et al
.
First basic performance evaluation of the XE-2100 haematology analyser
.
J Autom Methods Manag Chem
.
1999
;
21
(
4
):
127
-
133
.
28.
Johansson
K
,
Jansson
JH
,
Johansson
L
,
Ekblom
K
,
Lind
MM
.
Von Willebrand factor, ABO blood group, and risk of first-ever intracerebral hemorrhage: A prospective nested case-control study
.
Thromb Res
.
2020
;
195
:
77
-
80
.
29.
Dentali
F
,
Pomero
F
,
Annoni
F
, et al
.
Role of ABO blood group as a prognostic factor in patients with spontaneous intracerebral hemorrhage
.
J Thromb Haemost
.
2013
;
11
(
1
):
187
-
189
.
30.
Roh
D
,
Martin
A
,
Sun
C-H
, et al
.
ABO blood type and hematoma expansion after intracerebral hemorrhage: an exploratory analysis
.
Neurocrit Care
.
2019
;
31
(
1
):
66
-
71
.
31.
Refaai
MA
,
Fialkow
LB
,
Heal
JM
, et al
.
An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients
.
Vox Sang
.
2011
;
101
(
1
):
55
-
60
.
32.
Kazui
S
,
Naritomi
H
,
Yamamoto
H
,
Sawada
T
,
Yamaguchi
T
.
Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course
.
Stroke
.
1996
;
27
(
10
):
1783
-
1787
.
You do not currently have access to this content.

Sign in via your Institution

Sign In